Wednesday, December 18, 2019

SPARC signs pact with Bioprojet to acquire exclusive rights for drug to treat auto-immune diseases

SPARC signs pact with Bioprojet to acquire exclusive rights for drug to treat auto-immune diseases "SPARC... announced that it has entered into an agreement with Bioprojet SCR (Bioprojet) to exclusively acquire Bioprojet#39;s rights to the investigational medicinal product SCD-044," the company said.

from Moneycontrol Business News https://ift.tt/36QGuwQ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...